The House Republicans’ budget blueprint, blessed by Speaker Mike Johnson, has long been stalled in the chamber. On Tuesday, Arrington called for a Thursday committee meeting to resolve vast ...

If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Coverage of obesity drugs in health plans and ... to the health care industry in a recent webinar. GLP-1 drugs such as Ozempic and Wegovy have skyrocketed in popularity as more Americans take ...

Ozempic and Wegovy ... Trump administration’s approach to the negotiation process and the type of Medicare drug coverage an enrollee has. Those not eligible for Medicare will not benefit ...

The Trump administration will decide whether to expand coverage for millions of Americans. By Rebecca Robbins Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are ...

Weight loss drugs Ozempic and Wegovy have been added ... about 5.3 million people with Medicare Part D coverage used these drugs to treat a variety of conditions, such as cancer, type 2 diabetes ...

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy ... also proposed expanding Medicare coverage to weight loss drugs, which ...

Those drugs are: Ozempic/Wegovy/Rybelsus ... About 5.3 million people with Medicare prescription drug coverage used these medications from November 2023 through October 2024 at a cost of $ ...